Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/TAKEDA-PHARMACEUTICAL-COM-6491073/actualite/Takeda-Pharmaceutical-recoit-un-avis-positif-du-CHMP-pour-ALUNBRIG-brigatinib-comme-traitemen-30097598/?utm_source=whatsapp&utm_medium=social&utm_campaign=share